US Federal Judge orders Alfasigma to stop false claims. VSL#3® has never been studied in IBD, IBS, liver diseases or any other disease.
A federal jury in the United States District Court for the District of Maryland unanimously ruled on Nov. 18 in favor of myself and ExeGi Pharma, which distributes my Formulation in the US, against VSL Inc, Leadiant and Alfasigma, for False Advertising, Unjust Enrichment and Unpaid Royalties. The jury unanimously found [...]
The probiotic formulation of Pr. De Simone has been tested in over 5000 patients of all ages: 33 330 adult participants 1 682 children in pediatric studies 295 participants in geriatric studies The numerous studies and the large panel of participants have demonstrated the safe use of the De Simone [...]
The Simone Formulation has been tested worldwide Among the probiotics being studied, many are tested at a national level and in a confidential manner. The Simone Formulation is the subject of worldwide studies and international publications: 35 studies in Europe 11 studies in India 9 studies in the USA 4 studies [...]
Since 2000, the Simone Formulation has been studied in a wide range of therapeutic fields: 39 studies were carried out in the gastrointestinal area (Pouchitis, Ulcerative Colitis, Crohn's disease, IBD, diverticulitis, Microscopic colitis) 10 studies in liver diseases (Cirrhosis, Liver Failure, Hepatic Encephalopathy, Hepatic Steatosis) 11 studies in Bacterial Vaginosis, Sepsis, Dyspepsia, [...]
Rigorous clinical trial standards to test the Simone Formulation In any clinical study, it is essential to avoid any bias that may distort the results. The clinical studies carried out on the De Simone Formulation have been the subject of the following study design: 43 randomized and/or controlled trials (double-blind, placebo-controlled, cross-over, [...]